Literature DB >> 8995932

The relationship between gastroesophageal reflux disease and its complications with Barrett's esophagus.

G M Eisen1, R S Sandler, S Murray, M Gottfried.   

Abstract

BACKGROUND: Barrett's esophagus is a condition in which the stratified squamous epithelium of the esophagus is replaced by a columnar epithelium with malignant potential. Chronic gastroesophageal reflux disease (GERD) is accepted as the primary risk factor for the development of Barrett's esophagus, but only a small fraction of individuals with GERD develop Barrett's esophagus. We sought to identify factors that increase the risk of Barrett's esophagus in those with GERD.
OBJECTIVE: The objective of this matched case-control study was to investigate possible clinical risk factors for Barrett's esophagus.
METHODS: The study was based on 79 case patients with Barrett's esophagus and 180 control patients. Each case patient was matched to one control patient whose indication for endoscopy was GERD and one control patient who underwent endoscopy for other indications. The case and control patients were matched for age, gender, and race. All patients underwent endoscopy at Duke University Medical Center, Durham, NC, between July 1992 and August 1994.
RESULTS: On average, patients with Barrett's esophagus developed reflux symptoms at an earlier age than age- and gender-matched control patients and also had a longer duration of symptoms. Complications of reflux, including esophagitis, stricture, and ulceration, were reported significantly more frequently in the group of case patients than either group of control patients.
CONCLUSIONS: The results of this pilot study indicate that age of onset, duration of symptoms, and complications of GERD may be markers of increased risk of Barrett's esophagus.

Entities:  

Mesh:

Year:  1997        PMID: 8995932

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  44 in total

1.  A review of reflux esophagitis around the world.

Authors:  Edwin J Zarling
Journal:  World J Gastroenterol       Date:  1998-08       Impact factor: 5.742

2.  Barrett's esophagus: now what?

Authors:  Jeffrey H Peters
Journal:  Ann Surg       Date:  2003-03       Impact factor: 12.969

Review 3.  Barrett's esophagus with high-grade dysplasia: focus on current treatment options.

Authors:  Leonidas Lekakos; Nikolaos P Karidis; Dimitrios Dimitroulis; Christos Tsigris; Gregory Kouraklis; Nikolaos Nikiteas
Journal:  World J Gastroenterol       Date:  2011-10-07       Impact factor: 5.742

Review 4.  Barrett's esophagus.

Authors:  Jeffrey H Peters; Jeffrey A Hagen; Steven R DeMeester
Journal:  J Gastrointest Surg       Date:  2004-01       Impact factor: 3.452

Review 5.  How should Barrett's ulceration be treated?

Authors:  J H Peters; K K Wang
Journal:  Surg Endosc       Date:  2004-01-12       Impact factor: 4.584

Review 6.  Barrett esophagus: an update.

Authors:  Rami J Badreddine; Kenneth K Wang
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2010-06-01       Impact factor: 46.802

Review 7.  The importance of symptom assessment in the surgical treatment of gastroesophageal reflux disease and Barrett's esophagus.

Authors:  J H Peters
Journal:  Surg Endosc       Date:  2006-03-16       Impact factor: 4.584

Review 8.  Esophageal testing: What we have so far.

Authors:  Nicola de Bortoli; Irene Martinucci; Lorenzo Bertani; Salvatore Russo; Riccardo Franchi; Manuele Furnari; Salvatore Tolone; Giorgia Bodini; Valeria Bolognesi; Massimo Bellini; Vincenzo Savarino; Santino Marchi; Edoardo Vincenzo Savarino
Journal:  World J Gastrointest Pathophysiol       Date:  2016-02-15

9.  Clinical and histologic follow-up after antireflux surgery for Barrett's esophagus.

Authors:  Steven P Bowers; Samer G Mattar; C Daniel Smith; J Patrick Waring; John G Hunter
Journal:  J Gastrointest Surg       Date:  2002 Jul-Aug       Impact factor: 3.452

10.  Esophageal cancer incidence rates by histological type and overall: Puerto Rico versus the United States Surveillance, Epidemiology, and End Results population, 1992-2005.

Authors:  Lorena González; Priscilla Magno; Ana P Ortiz; Karen Ortiz-Ortiz; Kenneth Hess; Graciela M Nogueras-González; Erick Suárez
Journal:  Cancer Epidemiol       Date:  2012-10-11       Impact factor: 2.984

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.